GENTA INCORPORATED. By: --------------------------------------- Authorized Officer CHASEMELLON SHAREHOLDER SERVICES, as Warrant Agent By: --------------------------------------- Authorized Officer PARAMOUNT CAPITAL, INC. By: --------------------------------------- Authorized Officer EXHIBIT A [FORM OF FACE OF CLASS D WARRANT CERTIFICATE] No. __ _______________ Class D Warrants VOID AFTER __________________, 2002 CLASS D WARRANT CERTIFICATE FOR PURCHASE OF COMMON STOCK GENTA INCORPORATED This certifies that FOR VALUE RECEIVED ________________________________________________________________________________ ___________________________ or registered assigns (the "Registered Holder") is the owner of the number of Class D Warrants ("Class D Warrants") specified above. Each Class D Warrant represented hereby initially entitles the Registered Holder to purchase, subject to the terms and conditions set forth in this Warrant Certificate and the Warrant Agreement (as hereinafter defined), one fully paid and nonassessable share of Common Stock, par value $.001 per share ("Common Stock"), of Genta Incorporated, a Delaware corporation (the "Company"), at any time between _______________, 1997, and the Expiration Date (as hereinafter defined), upon the presentation and surrender of this Warrant Certificate with the Subscription Form on the reverse hereof duly executed, at the corporate office of ChaseMellon Shareholder Services, L.L.C., as Warrant Agent, or its successor (the "Warrant Agent"), accompanied by payment of the Purchase Price (as defined in the Warrant Agreement) in lawful money of the United States of America in cash or by official bank or certified check made payable to the Company. This Warrant Certificate and each Class D Warrant represented hereby are issued pursuant to, and are subject in all respects to, the terms and conditions set forth in the Warrant Agreement (the "Warrant Agreement"), dated as of May 20, 1997, by and among the Company, the Warrant Agent and Paramount Capital, Inc. In the event of certain contingencies provided for in the Warrant Agreement, the Purchase Price or the number of shares of Common Stock subject to purchase upon the exercise of each Class D Warrant represented hereby are subject to modification or adjustment. Each Class D Warrant represented hereby is exercisable at the option of the Registered Holder, but no fractional shares of Common Stock will be issued. In the case of the exercise of fewer than every Class D Warrant represented hereby,...
GENTA INCORPORATED. By: ---------------------------------- Name: Raymond P. Warrell, Jr., X.X. Title: Chairman & Chief Executive Officer AVENTIS PHARMACEUTICALS INC. By: ---------------------------------- Name: Gerald P. Belle Title: Xxxxxxxxt and Chief Executive Officer EXHIBIT 1.24 G3139 USAN Name (NN-70): Oblimersen Sodium Manufacturer: Genta Incorporated Therapeutic Claim: Treatment of cancer and rheumatological diseases (an antisense oligonucleotide) Chemical names: deoxyribose, phosphorothioate, (tct-ccc-agc-gtg-cgc-cat) [5' -> 3'] DNA, d(P-thio)(T-C-T-C-C-C-A-G-C-G-T-G-C-G-C-C-A-T) Code Designation: G3139 Molecular Formula, acid form: C H N O P S 172 221 62 91 17 17 Molecular Weight, acid form: 5684.59 Molecular Formula, sodium form: C H N O P S Na 172 204 62 91 17 17 17 Molecular weight, xxxxxx xxxx: 0000.00 XXX Xxxxxxxy Number: 190977-41-4 WHO Number: 8267 Structural Formula: The structure of the sodium-salt form of G3139 is provided on the following page. The configuration of all ribofuranosyl groups is "D". Structure of G3139 Sodium Salt [GRAPHIC OMITTED]
GENTA INCORPORATED. New Class A Bridge Warrant for the Purchase of Shares of -------------------------------------------------------- Common Stock ------------ No. CA-1 350,000 Shares
GENTA INCORPORATED. By: /s/ Xxxxxx X. Xxxxx ----------------------- ----------------------- Name: Xx. Xxxxxx
GENTA INCORPORATED. Name: Dr.
GENTA INCORPORATED. IDIS LIMITED SUPPLY AND DISTRIBUTION AGREEMENT DATE PARTIES
GENTA INCORPORATED. Dated: By: ---------------- -----------------------------------
GENTA INCORPORATED. By: ------------------------- Name: Mark X. Xxxxxx Title: Chairman of the Board of Directors
GENTA INCORPORATED. By: /s/ MICHAEL WEISS ------------------------------- Name: Michael Weiss Title: Cxxxxxxx xx xxe Compensation Committee of the Board Date: May 16, 2003 AGREED AND ACCEPTED: /s/ RAYMOND P. WARRELL, JR., M.D. --------------------------------- Dr. Xxxxxxx X. Xxxxxxx, Xx. Date: May 16, 2003 EXHIBIT A FORM OF STOCK OPTION AGREEMENT
GENTA INCORPORATED. By: /s/ WILLIAM P. KEANE --------------------------- Name: William P. Keane Xxxxx: Xxxx Xresident & CFO I hereby accept the Option described in this Agreement, and I agree to be bound by the terms of the Plan and this Agreement. I hereby further agree that all the decisions and determinations of the Committee with respect to this Agreement and the Plan shall be final and binding. OPTIONEE Loretta Itri, M.D. /x/ XXXXXTA M. ITRI, M.D. ------------------------------- Signature Address: C/o Genta Incorporated Xxx Xxxxxxx Xxxxx Xxxxxxxx Xxxxxxx, NJ 07922 Itri Stock Option Grant Agreement 35 Schedule 1.2 ----------------------------------------------------------------------------------------------------------- Option Grant Date # Shares Granted Exercise Price Vesting Schedule Termination Date Option Type ----------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------- 3/28/01 60,000 $5.73 Upon FDA 3/28/11 Non Qualified approval of Genasense ----------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------- 3/28/01 69,808 $5.73 25% per year 3/28/11 Incentive ----------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------- 3/28/01 170,192 $5.73 25% per year 3/28/11 Non Qualified ----------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------- 1/25/02 30,000 $13.70 25% per year 1/25/12 Non Qualified ----------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------- 1/28/03 15,000 $7.861 25% per year 1/28/13 Non Qualified ----------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------- 1/28/03 15,000 $7.861 25% per year 1/28/13 Incentive --------------------------------------------...
